![Kevin Sarney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Sarney
Finansdirektör/CFO på
ATARA BIOTHERAPEUTICS, INC.
Profil
Kevin G.
Sarney is Chief Financial Officer at Atara Biotherapeutics, Inc. since 2026.
Formerly, Mr. Sarney was Chief Accounting Officer at NitroMed, Inc., Vice President-Finance & Administration at Avaxia Biologics, Inc. from 2013 to 2014, and Chief Accounting Officer & Vice President-Finance at Enumeral Biomedical Holdings, Inc. from 2014 to 2018.
Education includes an MBA from Boston University, graduate studies at Suffolk University, and undergraduate studies at the University of Hartford.
Aktiva positioner av Kevin Sarney
| Företag | Position | Start |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Finansdirektör/CFO | 2026-06-26 |
Tidigare kända positioner av Kevin Sarney
| Företag | Position | Slut |
|---|---|---|
| ENUMERAL BIOMEDICAL HOLDINGS INC | Verkställande Direktör | - |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Finansdirektör/CFO | 2014-07-01 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Comptroller/Controller/Revisor | 2009-01-27 |
Kevin Sarneys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
23
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
 University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
